Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Jun;61(6):861–865. doi: 10.1038/bjc.1990.192

Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats.

L Bokser 1, B Szende 1, A V Schally 1
PMCID: PMC1971695  PMID: 2142603

Abstract

The possible protective effect of an agonist of luteinising hormone-releasing hormone (LH-RH) against the ovarian damage caused by cyclophosphamide was investigated in rats. D-Trp6-LH-RH microcapsules were injected once a month for 3 months, in a dose calculated to release 25 micrograms day-1. Control animals received the injection vehicle. Sixty days after the first injection of microcapsules, cyclophosphamide was given at a loading dose of 50 mg kg-1 followed by 5 mg kg-1 day-1 for 30 days, while the treatment with D-Trp6-LH-RH was continued. When the ovaries were examined 3 months and 5 months after discontinuation of treatment, a significant reduction in the total number of follicles (P less than 0.01) was found in non-pretreated animals given cyclophosphamide. This reduction affected mainly follicles larger than 100 microns. An irreversible disintegration and destruction of granulosa cells was also observed in this group. In animals pretreated with D-Trp6-LH-RH, administration of cyclophosphamide caused no reduction in the number and diameter of follicles. Thus, the treatment with D-Trp6-LH-RH microcapsules before and during chemotherapy prevented the ovarian injury inflicted by cyclophosphamide. The suppression of gonadal function by LH-RH analogues could be possibly utilised for the protection of the ovaries against damage caused by cytotoxic drugs.

Full text

PDF
862

Images in this article

863Figure 2
on p.863

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham G. E. Radioimmunoassay of steroids in biological fluids. Clin Biochem. 1974 Sep;7(3):193–201. doi: 10.1016/s0009-9120(74)91856-6. [DOI] [PubMed] [Google Scholar]
  2. Ataya K. M., McKanna J. A., Weintraub A. M., Clark M. R., LeMaire W. J. A luteinizing hormone-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats. Cancer Res. 1985 Aug;45(8):3651–3656. [PubMed] [Google Scholar]
  3. Ataya K., Tadros M., Ramahi A. Gonadotropin-releasing hormone agonist inhibits physiologic ovarian follicular loss in rats. Acta Endocrinol (Copenh) 1989 Jul;121(1):55–60. doi: 10.1530/acta.0.1210055. [DOI] [PubMed] [Google Scholar]
  4. Bajusz S., Csernus V. J., Janaky T., Bokser L., Fekete M., Schally A. V. New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues. Int J Pept Protein Res. 1988 Dec;32(6):425–435. doi: 10.1111/j.1399-3011.1988.tb01373.x. [DOI] [PubMed] [Google Scholar]
  5. Bokser L., Zalatnai A., Schally A. V. Inhibition of pituitary-gonadal axis in mice by long-term administration of D-Trp-6-LHRH microcapsules. J Reprod Fertil. 1989 Mar;85(2):569–574. doi: 10.1530/jrf.0.0850569. [DOI] [PubMed] [Google Scholar]
  6. Chapman R. M., Sutcliffe S. B., Malpas J. S. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. JAMA. 1979 Oct 26;242(17):1877–1881. [PubMed] [Google Scholar]
  7. Chapman R. M., Sutcliffe S. B. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood. 1981 Oct;58(4):849–851. [PubMed] [Google Scholar]
  8. Csernus V. J., Szende B., Groot K., Redding T. W., Schally A. V. Development of radioimmunoassay for a potent luteinizing hormone-releasing hormone antagonist. Evaluation of serum levels after injection of [Ac-3-(2-naphthyl)-D-Ala1, D-Phe(pCl)2, 3-(3-pyridyl)-D-Ala3, D-Cit6, D-Ala10] LHRH. Arzneimittelforschung. 1990 Feb;40(2 Pt 1):111–118. [PubMed] [Google Scholar]
  9. Damewood M. D., Grochow L. B. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril. 1986 Apr;45(4):443–459. doi: 10.1016/s0015-0282(16)49268-x. [DOI] [PubMed] [Google Scholar]
  10. Delic J. I., Bush C., Peckham M. J. Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen. Cancer Res. 1986 Apr;46(4 Pt 2):1909–1914. [PubMed] [Google Scholar]
  11. Delic J. I., Harwood J. R., Stanley J. A. Time dependence for the protective effect of androgen from procarbazine-induced damage to rat spermatogenesis. Cancer Res. 1987 Mar 1;47(5):1344–1347. [PubMed] [Google Scholar]
  12. Frisch R. E., McArthur J. W. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science. 1974 Sep 13;185(4155):949–951. doi: 10.1126/science.185.4155.949. [DOI] [PubMed] [Google Scholar]
  13. Goodpasture J. C., Bergstrom K., Vickery B. H. Potentiation of the gonadotoxicity of Cytoxan in the dog by adjuvant treatment with a luteinizing hormone-releasing hormone agonist. Cancer Res. 1988 Apr 15;48(8):2174–2178. [PubMed] [Google Scholar]
  14. Gradishar W. J., Schilsky R. L. Effects of cancer treatment on the reproductive system. Crit Rev Oncol Hematol. 1988;8(2):153–171. doi: 10.1016/s1040-8428(88)80009-x. [DOI] [PubMed] [Google Scholar]
  15. Hardy B., Danon D., Eshkol A., Lunenfeld B. Ultrastructural changes in the ovaries of infant mice deprived of endogenous gonadotrophins and after substitution with FSH. J Reprod Fertil. 1974 Feb;36(2):345–352. doi: 10.1530/jrf.0.0360345. [DOI] [PubMed] [Google Scholar]
  16. Hirshfield A. N., Midgley A. R., Jr Morphometric analysis of follicular development in the rat. Biol Reprod. 1978 Oct;19(3):597–605. doi: 10.1095/biolreprod19.3.597. [DOI] [PubMed] [Google Scholar]
  17. Hulse G., Coleman G., Nicholas J., Greenwood K. Reversal of the anti-ovulatory action of stress in rats by prior administration of naloxone hydrochloride. J Reprod Fertil. 1982 Nov;66(2):451–456. doi: 10.1530/jrf.0.0660451. [DOI] [PubMed] [Google Scholar]
  18. JONES E. C., KROHN P. L. The effect of hypophysectomy on age changes in the ovaries of mice. J Endocrinol. 1961 Feb;21:497–509. doi: 10.1677/joe.0.0210497. [DOI] [PubMed] [Google Scholar]
  19. Jarrell J., Lai E. V., Barr R., McMahon A., Belbeck L., O'Connell G. Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rat. Cancer Res. 1987 May 1;47(9):2340–2343. [PubMed] [Google Scholar]
  20. Jarrell J., YoungLai E. V., McMahon A., Barr R., O'Connell G., Belbeck L. Effects of ionizing radiation and pretreatment with [D-Leu6,des-Gly10] luteinizing hormone-releasing hormone ethylamide on developing rat ovarian follicles. Cancer Res. 1987 Oct 1;47(19):5005–5008. [PubMed] [Google Scholar]
  21. Karashima T., Zalatnai A., Schally A. V. Protective effects of analogs of luteinizing hormone-releasing hormone against chemotherapy-induced testicular damage in rats. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2329–2333. doi: 10.1073/pnas.85.7.2329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lewis R. W., Dowling K. J., Schally A. V. D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons. Proc Natl Acad Sci U S A. 1985 May;82(9):2975–2979. doi: 10.1073/pnas.82.9.2975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lunenfeld B., Kraiem Z., Eshkol A. The function of the growing follicle. J Reprod Fertil. 1975 Dec;45(3):567–574. doi: 10.1530/jrf.0.0450567. [DOI] [PubMed] [Google Scholar]
  24. Mason-Garcia M., Vigh S., Comaru-Schally A. M., Redding T. W., Somogyvari-Vigh A., Horvath J., Schally A. V. Radioimmunoassay for 6-D-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long-acting microcapsule formulations. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1547–1551. doi: 10.1073/pnas.82.5.1547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Niswender G. D., Midgley A. R., Jr, Monroe S. E., Reichert L. E., Jr Radioimmunoassay for rat luteinizing hormone with antiovine LH serum and ovine LH-131-I. Proc Soc Exp Biol Med. 1968 Jul;128(3):807–811. doi: 10.3181/00379727-128-33129. [DOI] [PubMed] [Google Scholar]
  26. Nseyo U. O., Huben R. P., Klioze S. S., Pontes J. E. Protection of germinal epithelium with luteinizing hormone-releasing hormone analogue. J Urol. 1985 Jul;134(1):187–190. doi: 10.1016/s0022-5347(17)47054-6. [DOI] [PubMed] [Google Scholar]
  27. Redding T. W., Schally A. V. Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1459–1462. doi: 10.1073/pnas.80.5.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rivkees S. A., Crawford J. D. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA. 1988 Apr 8;259(14):2123–2125. [PubMed] [Google Scholar]
  29. Samaan N. A., deAsis D. N., Jr, Buzdar A. U., Blumenschein G. R. Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy. Cancer. 1978 Jun;41(6):2084–2087. doi: 10.1002/1097-0142(197806)41:6<2084::aid-cncr2820410603>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  30. Schally A. V., Coy D. H., Arimura A. LH-RH agonists and antagonists. Int J Gynaecol Obstet. 1980;18(5):318–324. doi: 10.1002/j.1879-3479.1980.tb00507.x. [DOI] [PubMed] [Google Scholar]
  31. Schally A. V., Paz-Bouza J. I., Schlosser J. V., Karashima T., Debeljuk L., Gandle B., Sampson M. Protective effects of analogs of luteinizing hormone-releasing hormone against x-radiation-induced testicular damage in rats. Proc Natl Acad Sci U S A. 1987 Feb;84(3):851–855. doi: 10.1073/pnas.84.3.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Vickery B. H. Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agonists and antagonists. Endocr Rev. 1986 Feb;7(1):115–124. doi: 10.1210/edrv-7-1-115. [DOI] [PubMed] [Google Scholar]
  33. Wang C., Ng R. P., Chan T. K., Todd D. Effect of combination chemotherapy on pituitary-gonadal function in patients with lymphoma and leukemia. Cancer. 1980 Apr 15;45(8):2030–2037. doi: 10.1002/1097-0142(19800415)45:8<2030::aid-cncr2820450807>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  34. da Cunha M. F., Meistrich M. L., Nader S. Absence of testicular protection by a gonadotropin-releasing hormone analogue against cyclophosphamide-induced testicular cytotoxicity in the mouse. Cancer Res. 1987 Feb 15;47(4):1093–1097. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES